ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Prospective Registry of Elderly ESUS With PFO
Recruiting
- Conditions
- Embolic Stroke of Undetermined Source
- Interventions
- Procedure: PFO closure
- First Posted Date
- 2022-02-14
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1200
- Registration Number
- NCT05238610
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
Phase 3
Recruiting
- Conditions
- Advanced Gastric Carcinoma
- Interventions
- Drug: FerinjectOther: Conservative management
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 330
- Registration Number
- NCT05226169
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy
Phase 2
Recruiting
- Conditions
- DNA Damage Repair DeficiencyBiliary Tract Cancer
- Interventions
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 62
- Registration Number
- NCT05222971
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
PENK Methylation Test for Detecting Bladder Cancer
Recruiting
- Conditions
- Hematuria; BenignBladder Cancer
- Interventions
- Diagnostic Test: EarlyTect® Bladder Cancer test
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1549
- Registration Number
- NCT05220189
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Development of Dysphagia Evaluation Via Video Analysis Based on Deep Learning Method in Neonates and Infants and Correlation Between the Evaluation and the Development
Not Applicable
Recruiting
- Conditions
- Dysphagia of Newborn
- Interventions
- Diagnostic Test: AI analysis
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT05204966
- Locations
- 🇰🇷
Asan medical Center, Seoul, Korea, Republic of
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT05184803
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Prediction Model for Response to Biologics and Small Molecular Agent for UC
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT05186623
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Precision Medicine Intervention in Severe Asthma (PRISM) Study
- Conditions
- Severe Asthma
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT05164939
- Locations
- 🇰🇷
Asan medical center, Seoul, Songpagu, Korea, Republic of
🇬🇧Imperial college, London, United Kingdom
Albumin and Crystalloid Administration in Septic Shock
Phase 4
Recruiting
- Conditions
- Septic Shock
- Interventions
- Drug: TreatmentDrug: Placebo
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 2426
- Registration Number
- NCT05148286
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma
Not Applicable
- Conditions
- Patients With Suspected or Diagnosed Central Nervous System Lymphoma
- Interventions
- Drug: [18F]FET
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05083936
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-Gu, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath